Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis - PubMed (original) (raw)
Review
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al. Lancet Glob Health. 2014 Feb.
Free article
Abstract
Background: Numerous population-based studies of age-related macular degeneration have been reported around the world, with the results of some studies suggesting racial or ethnic differences in disease prevalence. Integrating these resources to provide summarised data to establish worldwide prevalence and to project the number of people with age-related macular degeneration from 2020 to 2040 would be a useful guide for global strategies.
Methods: We did a systematic literature review to identify all population-based studies of age-related macular degeneration published before May, 2013. Only studies using retinal photographs and standardised grading classifications (the Wisconsin age-related maculopathy grading system, the international classification for age-related macular degeneration, or the Rotterdam staging system) were included. Hierarchical Bayesian approaches were used to estimate the pooled prevalence, the 95% credible intervals (CrI), and to examine the difference in prevalence by ethnicity (European, African, Hispanic, Asian) and region (Africa, Asia, Europe, Latin America and the Caribbean, North America, and Oceania). UN World Population Prospects were used to project the number of people affected in 2014 and 2040. Bayes factor was calculated as a measure of statistical evidence, with a score above three indicating substantial evidence.
Findings: Analysis of 129,664 individuals (aged 30-97 years), with 12,727 cases from 39 studies, showed the pooled prevalence (mapped to an age range of 45-85 years) of early, late, and any age-related macular degeneration to be 8.01% (95% CrI 3.98-15.49), 0.37% (0.18-0.77), and 8.69% (4.26-17.40), respectively. We found a higher prevalence of early and any age-related macular degeneration in Europeans than in Asians (early: 11.2% vs 6.8%, Bayes factor 3.9; any: 12.3% vs 7.4%, Bayes factor 4.3), and early, late, and any age-related macular degeneration to be more prevalent in Europeans than in Africans (early: 11.2% vs 7.1%, Bayes factor 12.2; late: 0.5% vs 0.3%, 3.7; any: 12.3% vs 7.5%, 31.3). There was no difference in prevalence between Asians and Africans (all Bayes factors <1). Europeans had a higher prevalence of geographic atrophy subtype (1.11%, 95% CrI 0.53-2.08) than Africans (0.14%, 0.04-0.45), Asians (0.21%, 0.04-0.87), and Hispanics (0.16%, 0.05-0.46). Between geographical regions, cases of early and any age-related macular degeneration were less prevalent in Asia than in Europe and North America (early: 6.3% vs 14.3% and 12.8% [Bayes factor 2.3 and 7.6]; any: 6.9% vs 18.3% and 14.3% [3.0 and 3.8]). No significant gender effect was noted in prevalence (Bayes factor <1.0). The projected number of people with age-related macular degeneration in 2020 is 196 million (95% CrI 140-261), increasing to 288 million in 2040 (205-399).
Interpretation: These estimates indicate the substantial global burden of age-related macular degeneration. Summarised data provide information for understanding the effect of the condition and provide data towards designing eye-care strategies and health services around the world.
Funding: National Medical Research Council, Singapore.
Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by .. All rights reserved.
Comment in
- Global prevalence of age-related macular degeneration.
Jonas JB. Jonas JB. Lancet Glob Health. 2014 Feb;2(2):e65-6. doi: 10.1016/S2214-109X(13)70163-3. Epub 2014 Jan 3. Lancet Glob Health. 2014. PMID: 25104656 No abstract available.
Similar articles
- Global Incidence, Progression, and Risk Factors of Age-Related Macular Degeneration and Projection of Disease Statistics in 30 Years: A Modeling Study.
Wang Y, Zhong Y, Zhang L, Wu Q, Tham Y, Rim TH, Kithinji DM, Wu J, Cheng C, Liang H, Yu H, Yang X, Liu L. Wang Y, et al. Gerontology. 2022;68(7):721-735. doi: 10.1159/000518822. Epub 2021 Sep 21. Gerontology. 2022. PMID: 34569526 - Updates on the Epidemiology of Age-Related Macular Degeneration.
Jonas JB, Cheung CMG, Panda-Jonas S. Jonas JB, et al. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):493-497. doi: 10.22608/APO.2017251. Epub 2017 Sep 14. Asia Pac J Ophthalmol (Phila). 2017. PMID: 28906084 Review. - The estimated prevalence and incidence of late stage age related macular degeneration in the UK.
Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. Owen CG, et al. Br J Ophthalmol. 2012 May;96(5):752-6. doi: 10.1136/bjophthalmol-2011-301109. Epub 2012 Feb 13. Br J Ophthalmol. 2012. PMID: 22329913 Free PMC article. - Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Tham YC, et al. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26. Ophthalmology. 2014. PMID: 24974815 Review. - Geo-Epidemiology of Age-Related Macular Degeneration: New Clues Into the Pathogenesis.
Reibaldi M, Longo A, Pulvirenti A, Avitabile T, Russo A, Cillino S, Mariotti C, Casuccio A. Reibaldi M, et al. Am J Ophthalmol. 2016 Jan;161:78-93.e1-2. doi: 10.1016/j.ajo.2015.09.031. Epub 2015 Oct 24. Am J Ophthalmol. 2016. PMID: 26432929 Review.
Cited by
- Associations of mediterranean diet score and age-related macular degeneration in Korean elderly.
Jang W, Choi J, Kim H. Jang W, et al. BMC Public Health. 2024 Oct 16;24(1):2846. doi: 10.1186/s12889-024-20371-6. BMC Public Health. 2024. PMID: 39415143 - Long Term Visual Outcomes of an Extended Macular Vision IOL in Eyes with Macular Disease and Visually Insignificant Cataract.
Badalà F, Bona E, Devincenzi G, Nouri-Mahdavi K. Badalà F, et al. Clin Ophthalmol. 2024 Oct 4;18:2765-2775. doi: 10.2147/OPTH.S481570. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39386174 Free PMC article. - Functions of TRPs in retinal tissue in physiological and pathological conditions.
do Nascimento THO, Pereira-Figueiredo D, Veroneze L, Nascimento AA, De Logu F, Nassini R, Campello-Costa P, Faria-Melibeu ADC, Souza Monteiro de Araújo D, Calaza KC. do Nascimento THO, et al. Front Mol Neurosci. 2024 Sep 25;17:1459083. doi: 10.3389/fnmol.2024.1459083. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39386050 Free PMC article. Review. - Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin in Rabbits Shows Potential of Topical Eye Drops for Posterior Segment Treatment.
Bahrpeyma S, Jakubiak P, Alvarez-Sánchez R, Caruso A, Leuthardt M, Senn C, Del Amo EM, Urtti A. Bahrpeyma S, et al. Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):14. doi: 10.1167/iovs.65.12.14. Invest Ophthalmol Vis Sci. 2024. PMID: 39382881 Free PMC article. - Exploring new horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues.
Shirian JD, Shukla P, Singh RP. Shirian JD, et al. Eye (Lond). 2024 Oct 8. doi: 10.1038/s41433-024-03373-x. Online ahead of print. Eye (Lond). 2024. PMID: 39379521 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical